Top stories in infectious disease: Fluoroquinolones remain popular as UTI treatment despite warning, CDC warns about bacteria from dog saliva
Click Here to Manage Email Alerts
Among the top stories in infectious disease this week is how a black box warning failed to impact the use of fluoroquinolones as a UTI treatment and a reminder that dog and cat saliva can make humans sick.
Other top stories include reports that indicated MRSA colonization significantly increased the risk for subsequent infection, an HIV prevention intervention in young transgender women resulted in safer sex and concerns about the latest Ebola outbreak. – by Janel Miller
Fluoroquinolones most common UTI treatment despite black box warning
A clinical practice guideline issued by the Infectious Diseases Society of America in 2011 that recommends health care providers avoid the use of fluoroquinolones for uncomplicated urinary tract infections had no significant impact on prescribing practices, according to a recent study. Read more.
WHO chief ‘more worried’ about latest Ebola outbreak in Congo after visit
WHO’s top official visited areas of the latest Ebola virus outbreak in the Democratic Republic of the Congo and said he came away “more worried” than he already was after seeing the challenges facing responders on the ground. Read more.
Q&A: Bacteria in dog and cat saliva can make humans sick
Dogs are man’s best friend, but recent reports served as a reminder that they carry bacteria in their saliva that can cause disease, and even death, in humans. Read more.
MRSA colonization significantly increases risk for subsequent infection
MRSA colonization significantly increases the risk for subsequent MRSA infection during and after hospitalization, researchers reported in study findings published in Clinical Infectious Diseases. Read more.
HIV prevention intervention in young transgender women results in safer sex
An intervention to reduce the sexual risk for HIV in young transgender women resulted in a nearly 40% reduction of condomless sex acts at 1-year follow-up compared with participants who received standard of care, according to study results published in JAMA Pediatrics. Read more.